Simonsen Sebastian, Popolo Raffaele, Juul Sophie, Frandsen Frederik Weischer, Sørensen Per, Dimaggio Giancarlo
Stolpegaard Psychotherapy Centre, Mental Health Services, Capital Region of Denmark, Gentofte, Denmark.
Centro di Terapia Metacognitiva Interpersonale, Rome, Italy.
J Nerv Ment Dis. 2022 Mar 1;210(3):163-171. doi: 10.1097/NMD.0000000000001432.
Avoidant personality disorder (AvPD) is a severe but understudied condition. The current pilot project reports data on acceptability and outcomes of a novel treatment combining biweekly individual metacognitive interpersonal therapy (MIT) and weekly mentalization-based therapy (MBT) group therapy. A total of 30 patients with AvPD were consecutively included in the program. The primary outcome was AvPD-specific personality functioning measured by self-report after treatment. Secondary outcomes were symptom distress, interpersonal problems, quality of life, and psychosocial functioning. Twenty-two patients completed treatment, with a mean duration of 13 months. On the primary outcome, effect sizes were generally moderate to large (effect size range: 0.59-1.10). On secondary outcomes, effect sizes were large (effect size range: 0.77-2.3). Both in terms of acceptability and outcomes, results are promising for the combination of MIT and MBT for AvPD. The approach is a strong candidate for further investigation in future large-scale randomized controlled trial.
回避型人格障碍（AvPD）是一种严重但研究不足的病症。当前的试点项目报告了一种新型治疗方法的可接受性和结果，该方法将每两周一次的个体元认知人际治疗（MIT）与每周一次的基于心理化的团体治疗（MBT）相结合。共有30名回避型人格障碍患者连续纳入该项目。主要结局是治疗后通过自我报告测量的特定于回避型人格障碍的人格功能。次要结局是症状困扰、人际问题、生活质量和心理社会功能。22名患者完成了治疗，平均疗程为13个月。在主要结局方面，效应大小一般为中等至较大（效应大小范围：0.59 - 1.10）。在次要结局方面，效应大小较大（效应大小范围：0.77 - 2.3）。无论是在可接受性还是结局方面，MIT和MBT相结合治疗回避型人格障碍的结果都很有前景。该方法是未来大规模随机对照试验进一步研究的有力候选方法。
